Massachusetts Financial Services’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$587K	Buy	87,387 +1,077	+1%	+$7.24K	﹤0.01%	839
2025 Q1	$780K	Buy	86,310 +18,926	+28%	+$171K	﹤0.01%	819
2024 Q4	$1.17M	Sell	67,384 -2,010	-3%	-$34.8K	﹤0.01%	807
2024 Q3	$1.11M	Buy	+69,394	New	+$1.11M	﹤0.01%	789